The concern I've had all along has been how much dilution we will have when the dust settles. However, the notes can't convert until 9 months after an uplist- so at least 1.5 years from now- and at market prices- no discount. So I think that looks pretty favorable. Unfortunately we will have the $975K converted in the next few months. What doesn't make any sense though is how we could uplist in 9 months- we only have 80-85 million shares, so even with a r/s, it does't seem feasible.
(4)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links